Psybio Therapeutics Corp Stock Market Value
| PSYBF Stock | USD 0.0001 0.00 0.00% |
| Symbol | PsyBio |
PsyBio Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PsyBio Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PsyBio Therapeutics.
| 12/12/2022 |
| 12/01/2024 |
If you would invest 0.00 in PsyBio Therapeutics on December 12, 2022 and sell it all today you would earn a total of 0.00 from holding PsyBio Therapeutics Corp or generate 0.0% return on investment in PsyBio Therapeutics over 720 days. PsyBio Therapeutics is related to or competes with Rigel Pharmaceuticals, Geron, Verastem, Immutep, and Elevation Oncology. PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psych... More
PsyBio Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PsyBio Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PsyBio Therapeutics Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.122 | |||
| Maximum Drawdown | 20998.0 |
PsyBio Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PsyBio Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PsyBio Therapeutics' standard deviation. In reality, there are many statistical measures that can use PsyBio Therapeutics historical prices to predict the future PsyBio Therapeutics' volatility.| Risk Adjusted Performance | 0.1033 | |||
| Jensen Alpha | 301.89 | |||
| Total Risk Alpha | (115.49) | |||
| Treynor Ratio | 3.31 |
PsyBio Therapeutics Corp Backtested Returns
PsyBio Therapeutics is out of control given 3 months investment horizon. PsyBio Therapeutics Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.1, which implies the firm had a 0.1% return per unit of risk over the last 3 months. We have analyzed seventeen different technical indicators, which can help you to evaluate if expected returns of 12.7% are justified by taking the suggested risk. Use PsyBio Therapeutics Variance of 6620260.56, risk adjusted performance of 0.1033, and Coefficient Of Variation of 819.35 to evaluate company specific risk that cannot be diversified away. PsyBio Therapeutics holds a performance score of 7 on a scale of zero to a hundred. The company holds a Beta of 95.0, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PsyBio Therapeutics will likely underperform. Use PsyBio Therapeutics standard deviation, as well as the relationship between the maximum drawdown and day median price , to analyze future returns on PsyBio Therapeutics.
Auto-correlation | 0.48 |
Average predictability
PsyBio Therapeutics Corp has average predictability. Overlapping area represents the amount of predictability between PsyBio Therapeutics time series from 12th of December 2022 to 7th of December 2023 and 7th of December 2023 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PsyBio Therapeutics Corp price movement. The serial correlation of 0.48 indicates that about 48.0% of current PsyBio Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
PsyBio Therapeutics Corp lagged returns against current returns
Autocorrelation, which is PsyBio Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PsyBio Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of PsyBio Therapeutics returns to help us make a trade decision. For example, suppose you find that PsyBio Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
PsyBio Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PsyBio Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PsyBio Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PsyBio Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
PsyBio Therapeutics Lagged Returns
When evaluating PsyBio Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PsyBio Therapeutics pink sheet have on its future price. PsyBio Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PsyBio Therapeutics autocorrelation shows the relationship between PsyBio Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in PsyBio Therapeutics Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in PsyBio Pink Sheet
PsyBio Therapeutics financial ratios help investors to determine whether PsyBio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PsyBio with respect to the benefits of owning PsyBio Therapeutics security.